WS09.02 Biomarkers for monitoring the effect of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis. - Dolce, D.; Francalanci, M.; Orioli, T.; Campana, S.; Ravenni, N.; Camera, E.; Fevola, C.; Cavicchi, M.C.; Galici, V.; Neri, A.S.; Terlizzi, V.; Taccetti, G. (Journal of Cystic Fibrosis, 2024)